Nu Skin Enterprises (NYSE:NUS) Issues Q2 Earnings Guidance

Nu Skin Enterprises (NYSE:NUSGet Rating) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $0.75-0.85 for the period, compared to the consensus EPS estimate of $1.19. The company issued revenue guidance of $590-620 million, compared to the consensus revenue estimate of $695.60 million.Nu Skin Enterprises also updated its FY22 guidance to $3.60-3.90 EPS.

NUS traded up $1.10 during midday trading on Friday, hitting $44.48. The company’s stock had a trading volume of 714,360 shares, compared to its average volume of 816,088. Nu Skin Enterprises has a 52-week low of $39.40 and a 52-week high of $62.70. The firm has a 50-day moving average price of $46.92 and a two-hundred day moving average price of $47.65. The company has a current ratio of 1.65, a quick ratio of 0.89 and a debt-to-equity ratio of 0.29. The firm has a market cap of $2.22 billion, a P/E ratio of 16.47 and a beta of 1.24.

Nu Skin Enterprises (NYSE:NUSGet Rating) last released its earnings results on Wednesday, May 4th. The company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.72 by $0.04. Nu Skin Enterprises had a net margin of 5.28% and a return on equity of 22.12%. The business had revenue of $604.90 million for the quarter, compared to analysts’ expectations of $579.70 million. During the same period last year, the company earned $0.91 earnings per share. The company’s quarterly revenue was down 10.7% on a year-over-year basis. On average, equities analysts expect that Nu Skin Enterprises will post 3.75 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 8th. Stockholders of record on Friday, May 27th will be paid a dividend of $0.385 per share. The ex-dividend date of this dividend is Thursday, May 26th. This represents a $1.54 annualized dividend and a dividend yield of 3.46%. Nu Skin Enterprises’s dividend payout ratio is presently 57.04%.

Several research analysts recently weighed in on the company. Zacks Investment Research raised Nu Skin Enterprises from a hold rating to a strong-buy rating and set a $57.00 target price on the stock in a research report on Tuesday, March 29th. TheStreet lowered Nu Skin Enterprises from a b rating to a c+ rating in a research note on Friday, February 18th. Jefferies Financial Group boosted their target price on Nu Skin Enterprises from $61.00 to $75.00 in a report on Thursday, February 17th. StockNews.com upgraded shares of Nu Skin Enterprises from a hold rating to a buy rating in a report on Thursday. Finally, DA Davidson boosted their price objective on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the stock a neutral rating in a research note on Thursday, February 17th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Nu Skin Enterprises currently has a consensus rating of Buy and a consensus target price of $60.60.

In related news, CEO Ryan S. Napierski sold 25,000 shares of Nu Skin Enterprises stock in a transaction on Friday, February 25th. The shares were sold at an average price of $47.40, for a total value of $1,185,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Andrew D. Lipman sold 1,000 shares of the company’s stock in a transaction on Friday, April 22nd. The shares were sold at an average price of $47.72, for a total transaction of $47,720.00. Following the completion of the sale, the director now directly owns 71,214 shares in the company, valued at $3,398,332.08. The disclosure for this sale can be found here. Insiders have sold a total of 28,000 shares of company stock worth $1,333,390 over the last three months. 2.80% of the stock is currently owned by corporate insiders.

Institutional investors have recently modified their holdings of the company. Janus Henderson Group PLC acquired a new position in shares of Nu Skin Enterprises in the 3rd quarter worth approximately $208,000. Schonfeld Strategic Advisors LLC bought a new stake in Nu Skin Enterprises during the fourth quarter valued at $455,000. Allstate Corp increased its stake in Nu Skin Enterprises by 12.4% during the fourth quarter. Allstate Corp now owns 15,684 shares of the company’s stock valued at $796,000 after purchasing an additional 1,733 shares during the last quarter. Vident Investment Advisory LLC lifted its position in shares of Nu Skin Enterprises by 4.4% in the 4th quarter. Vident Investment Advisory LLC now owns 33,578 shares of the company’s stock worth $1,703,000 after buying an additional 1,401 shares during the last quarter. Finally, UBS Group AG boosted its holdings in shares of Nu Skin Enterprises by 13.3% in the 3rd quarter. UBS Group AG now owns 42,922 shares of the company’s stock valued at $1,737,000 after buying an additional 5,040 shares during the period. Institutional investors and hedge funds own 93.79% of the company’s stock.

Nu Skin Enterprises Company Profile (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Featured Stories

Earnings History and Estimates for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.